Amylyx Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

아밀릭스 파머슈티컬스NASDAQ:AMLX · Nasdaq · Healthcare

$27.79-1.03%

2026-10-02 close

Amylyx Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $87M. 2024 operating profit was −$315M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy